Judit Liaño-Pons

10PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical devicesMolecular targetsCellular nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 18, 2025
Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment.

Judit Liaño-Pons, Elisa Garde-Lapido, Fenja L Fahrig

|Apr 30, 2025
Engineered Peptide Coacervates Enable Efficient Intracellular Delivery of the MYC Inhibitor omoMYC.

Carmine P Cerrato, Martin Krkoška, Yue Sun

|Nov 16, 2024
EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma.

Muhammad Mushtaq, Judit Liaño-Pons, Jiansheng Wang

|Aug 05, 2024
Defining neuroblastoma: From origin to precision medicine.

Lourdes Sainero-Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo

|Feb 29, 2024
A druggable conformational switch in the c-MYC transactivation domain.

Dilraj Lama, Thibault Vosselman, Cagla Sahin

Pageof 2